SS

Steven St. Peter

Managing Director at JDRF T1D Fund

Boston, Massachusetts

Overview

Work Experience

  • Founder and Managing Director

    2012 - Current

  • Managing Director

    2019

    The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life-changing solutions to cure, prevent, and treat type1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, corporations and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, diagnostics, and devices into the hands of those living with T1D. The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research.

  • Chairman Of The Supervisory Board

    2019 - 2020

    iOmx Therapeutics AG focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoints hijacked by cancer cells. iOmx is building a pipeline of promising cancer immunotherapeutics based on novel, proprietary targets with a known mode of action. Founded in 2016 based on the work conducted at the German Cancer Research Center, the company has been funded by MPM Capital , Sofinnova Partners, Wellington Partners and Merck Ventures and is based in Martinsried / Munich, Germany.

  • President & CEO

    2012 - 2019

  • Managing Director

    2004 - 2012

    Sourced, led, and managed investments.

  • Principal

    2001 - 2003

    Venture Capital

  • Senior Associate

    1999 - 2001

  • Analyst

    1989 - 1991

Relevant Websites